EARNEST Partners’s BioDelivery Sciences International, Inc. BDSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-2,800
| Closed | -$9K | – | 1202 |
|
|
2021
Q4 | $9K | Hold |
2,800
| – | – | ﹤0.01% | 718 |
|
|
2021
Q3 | $10K | Hold |
2,800
| – | – | ﹤0.01% | 667 |
|
|
2021
Q2 | $10K | Hold |
2,800
| – | – | ﹤0.01% | 676 |
|
|
2021
Q1 | $11K | Hold |
2,800
| – | – | ﹤0.01% | 618 |
|
|
2020
Q4 | $12K | Hold |
2,800
| – | – | ﹤0.01% | 581 |
|
|
2020
Q3 | $10K | Hold |
2,800
| – | – | ﹤0.01% | 580 |
|
|
2020
Q2 | $12K | Hold |
2,800
| – | – | ﹤0.01% | 530 |
|
|
2020
Q1 | $11K | Hold |
2,800
| – | – | ﹤0.01% | 496 |
|
|
2019
Q4 | $18K | Hold |
2,800
| – | – | ﹤0.01% | 475 |
|
|
2019
Q3 | $12K | Hold |
2,800
| – | – | ﹤0.01% | 558 |
|
|
2019
Q2 | $13K | Hold |
2,800
| – | – | ﹤0.01% | 533 |
|
|
2019
Q1 | $15K | Hold |
2,800
| – | – | ﹤0.01% | 499 |
|
|
2018
Q4 | $10K | Hold |
2,800
| – | – | ﹤0.01% | 556 |
|
|
2018
Q3 | $8K | Hold |
2,800
| – | – | ﹤0.01% | 651 |
|
|
2018
Q2 | $8K | Hold |
2,800
| – | – | ﹤0.01% | 646 |
|
|
2018
Q1 | $6K | Hold |
2,800
| – | – | ﹤0.01% | 718 |
|
|
2017
Q4 | $8K | Buy |
+2,800
| New | +$7.74K | ﹤0.01% | 621 |
|
|
2017
Q1 | – | Sell |
-2,800
| Closed | -$5K | – | 1164 |
|
|
2016
Q4 | $5K | Hold |
2,800
| – | – | ﹤0.01% | 717 |
|
|
2016
Q3 | $8K | Hold |
2,800
| – | – | ﹤0.01% | 354 |
|
|
2016
Q2 | $7K | Hold |
2,800
| – | – | ﹤0.01% | 360 |
|
|
2016
Q1 | $9K | Hold |
2,800
| – | – | ﹤0.01% | 359 |
|
|
2015
Q4 | $13K | Hold |
2,800
| – | – | ﹤0.01% | 333 |
|
|
2015
Q3 | $16K | Hold |
2,800
| – | – | ﹤0.01% | 310 |
|
|
2015
Q2 | $22K | Hold |
2,800
| – | – | ﹤0.01% | 287 |
|
|
2015
Q1 | $29K | Hold |
2,800
| – | – | ﹤0.01% | 265 |
|
|
2014
Q4 | $34K | Hold |
2,800
| – | – | ﹤0.01% | 265 |
|
|
2014
Q3 | $48K | Hold |
2,800
| – | – | ﹤0.01% | 235 |
|
|
2014
Q2 | $34K | Hold |
2,800
| – | – | ﹤0.01% | 265 |
|
|
2014
Q1 | $24K | Sell |
2,800
-1,200
| -30% | -$9.68K | ﹤0.01% | 281 |
|
|
2013
Q4 | $24K | Buy |
+4,000
| New | +$20.6K | ﹤0.01% | 328 |
|
Other funds holding BDSI
EARNEST Partners's BDSI Position: Q1 2022 in Review
EARNEST Partners sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 2,800 shares — an estimated $9K sold.
EARNEST Partners first reported a position in BDSI in Q4 2013 and held it in 30 quarters. The position peaked at $48K in Q3 2014. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.
- EARNEST Partners reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
- EARNEST Partners sold 2,800 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $9K.
- EARNEST Partners first reported a position in BioDelivery Sciences International, Inc. in Q4 2013 and held it in 30 quarters.
- EARNEST Partners's BioDelivery Sciences International, Inc. position peaked at $48K in Q3 2014.
- 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.
Based on EARNEST Partners's 13F filing for Q1 2022, filed 16 May 2022.